MYCN/MYC-mediated drug resistance mechanisms in neuroblastoma

Int J Clin Pharmacol Ther. 2010 Jul;48(7):489-91. doi: 10.5414/cpp48489.

Authors

S Gogolin¹, D Dreidax, G Becker, V Ehemann, M Schwab, F Westermann

Affiliation

¹ Division of Tumor Genetics, University of Heidelberg, Heidelberg, Germany.

PMID: 20557856
DOI: 10.5414/cpp48489

No abstract available

MeSH terms

Apoptosis / drug effects
Cell Line, Tumor
DNA Damage
Drug Resistance, Neoplasm
Humans
N-Myc Proto-Oncogene Protein
Neuroblastoma / drug therapy*
Neuroblastoma / pathology
Nuclear Proteins / physiology*
Oncogene Proteins / physiology*

Substances

MYCN protein, human
N-Myc Proto-Oncogene Protein
Nuclear Proteins
Oncogene Proteins